Transcat Blog

How Are Defibrillators Calibrated?

When a cardiac emergency occurs, a defibrillator must perform exactly as intended. These life-saving devices are designed to deliver a controlled electrical shock that can help restore a normal heart rhythm. Because patient safety depends on accurate performance, regular calibration and testing are essential parts of maintaining defibrillator reliability.

Healthcare facilities, emergency response organizations, and medical equipment providers rely on routine calibration to verify that their defibrillators continue to operate within manufacturer specifications. At Transcat, our ISO-accredited calibration laboratories provide calibration services for a wide range of medical equipment, including defibrillators, helping ensure these critical devices remain ready for use when needed most.

Why Does Defibrillator Calibration Matter?

Defibrillators are used in some of the most time-sensitive medical situations. An inaccurate shock output, malfunctioning display,

ROCHESTER, NY, November 2, 2026 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of test measurement, control and calibration, today announced that management will attend the Baird 2026 Global Industrial Conference and 2026 Stephens Annual Investment Conference in November 2026. Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Tom Barbato will attend the Baird 2026 Global Industrial Conference and 2026 Stephens Annual Investment Conference in November 2026, where they are scheduled to host one-on-one meetings with institutional investors at each event. Mr. Irick and Mr. Barbato will also host an in-person presentation at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, at 11:25 a.m. Central time.

ROCHESTER, NY, October 20, 2026 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services and test and measurement equipment, announced that it will release its results for the second quarter fiscal year 2027 ended September 26, 2026 after the close of financial markets on Tuesday, November 3, 2026.

Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will host a conference call and webcast on Tuesday, November 3, 2026 at 4:30 p.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.

Companies with the most stringent quality standards trust their calibration needs to Transcat. With the highest scope of accreditation in the industry, we pride ourselves on delivering quality, reliable calibration services.

Calibration can mean different things to different people, depending on who you ask.

Calibration is the process of testing a measurement instrument to verify its accuracy. If measurement deviations are found, we make adjustments so the instrument provides reliable and consistent results.

Transcat offers accredited calibration services you can trust for accuracy and consistency. Every year we test and verify over 10 million data points utilizing our industry-leading investments in our people, processes, system support resources and equipment. We are driven by one objective: 100% Satisfaction.

Organizations across industries rely on measurement data to make critical decisions about product quality, safety, compliance,

August 31, 2026 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services and test and measurement equipment, announced that it has acquired privately-held Southeastern Biomedical Associates Incorporated (“Southeastern”) effective August 31, 2026.

The $12.8 million purchase price was paid in cash and is subject to certain customary adjustments and holdback provisions.

Southeastern, founded in 1996 and based in Granite Falls, North Carolina, provides calibration, repair, preventive maintenance, electrical safety inspection, and documentation and regulatory compliance services to hospital networks and healthcare facilities throughout the southeastern United States and beyond that conform to both ISO/IEC 17025 and ISO 9001 standards. Southeastern also sells biomedical equipment, patient-ready accessories, and equipment parts, and assists customers with equipment acquisition and asset liquidation. This acquisition complements Transcat's

ROCHESTER, NY, August 27, 2026 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of test measurement, control and calibration, today announced that management will attend the 2026 Jefferies Global Industrials Conference, Lake Street Capital Markets 10th Annual Best Ideas Growth (“BIG10”) Conference, and D.A. Davidson 25th Annual Diversified Industrials & Services Conference in September 2026.

Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will attend the 2026 Jefferies Global Industrials Conference and the Lake Street Capital Markets 10th Annual Best Ideas Growth (“BIG10”) Conference, where they are scheduled to host one-on-one meetings with institutional investors at each event. Mr. Irick and Mr. Barbato will also host an in-person presentation at the 2026 Jefferies Global Industrials Conference on Wednesday, September 9, 2026, at 3:30 p.m. Eastern time.

Mr. Barbato and Director of Finance John Howe